Arboviruses are detected through the Mosquito′s Systemic Immune Response

Jeanette Lewis^*
*Correspondence: Jeanette Lewis, Department of Pharmacology, Utrecht University, Utrecht, Netherlands, Email:

Keywords

Arboviruses • Immune Deficiency (IMD) • RNAi pathway • Immune response

Introduction

Arthropod-borne viruses, known as arboviruses, are a diverse group of viruses that encompass numerous human pathogens responsible for significant outbreaks worldwide. These viruses are primarily transmitted by hematophagous arthropods, with mosquitoes being the most prominent vectors. When a mosquito ingests a blood meal from an infected host, the virus establishes an infection in the insect's midgut, leading to dissemination to other tissues, including the salivary glands. When the mosquito subsequently feeds on a new host, it can transmit the virus, initiating the human or animal infection cycle. Mosquitoes possess a well-developed immune system that acts as a primary defense against invading pathogens, including arboviruses. Their immune response involves both innate and adaptive components that work together to detect and neutralize these viral invaders. The mosquito's systemic immune response plays a pivotal role in determining whether an arbovirus can establish an infection within the insect or if it is effectively neutralized. The innate immune system is the mosquito's first line of defense against invading pathogens. It comprises various molecular and cellular mechanisms that recognize and eliminate pathogens rapidly. Key components of the mosquito's innate immune response include the Toll, Immune Deficiency (IMD), and Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathways.

Literature Review

Upon detecting viral components, such as double-stranded RNA (dsRNA) produced during arbovirus replication, the mosquito's innate immune system is triggered. This activation leads to the expression of Antimicrobial Peptides (AMPs), which are essential effectors in combating viral infections. AMPs disrupt the viral envelope, inhibit viral entry, or target viral replication, limiting the virus's ability to establish infection. Another critical component of the mosquito's innate immune response against arboviruses is the RNA interference (RNAi) pathway. RNAi is a post-transcriptional gene silencing mechanism that plays a fundamental role in controlling gene expression. When a virus infects a mosquito, it generates viral dsRNA molecules during replication. These dsRNA molecules trigger the production of Small Interfering RNAs (siRNAs) through the RNAi pathway. The siRNAs then guide the Argonaute protein to specifically target and degrade viral RNA, preventing viral replication and spread [1].

The RNAi pathway in mosquitoes has been shown to be highly effective against various arboviruses, including Dengue virus, Chikungunya virus, and Zika virus. Understanding the interplay between arboviruses and the RNAi pathway has opened up new avenues for developing innovative vector control strategies based on RNAi-mediated gene silencing. The mosquito's midgut is the initial site of arbovirus infection following a blood meal. However, not all ingested viruses can successfully establish an infection within the midgut. The midgut acts as a physical and immunological barrier against viral invasion. It produces Reactive Oxygen Species (ROS) and activates autophagy pathways to limit viral replication.

Furthermore, the midgut epithelial cells sense invading pathogens and initiate an antiviral immune response. For example, when arboviruses breach the midgut barrier, they interact with Pattern Recognition Receptors (PRRs) present on the surface of midgut cells. These interactions trigger downstream signalling pathways, leading to the production of antiviral effectors, such as AMPs and siRNAs. To establish a successful infection, arboviruses must overcome the midgut barriers and disseminate to other tissues, particularly the salivary glands. The mosquito's systemic immune response plays a crucial role in controlling this dissemination.

When arboviruses cross the midgut barrier, they encounter the mosquito's hemolymph, which contains immune cells called haemocytes. Haemocytes can recognize and phagocytize invading pathogens, limiting viral spread. Additionally, the JAK/STAT pathway activated during the systemic immune response induces the expression of antiviral effectors that inhibit viral replication in the hemolymph. Moreover, the mosquito's fat body, a crucial organ involved in metabolism and immune response, produces antiviral peptides and other immune-related molecules that contribute to limiting arbovirus dissemination. The orchestrated action of these components within the mosquito's systemic immune response plays a pivotal role in curbing arboviral infections.

Mosquitoes can mount immune responses not only against the currently infecting arbovirus but also generate immune priming and memory responses. Immune priming occurs when a mosquito is exposed to a sub lethal dose of an arbovirus, leading to an enhanced immune response upon subsequent viral exposure. This phenomenon can provide protection against future infections with the same or related arboviruses. Immune memory in mosquitoes is a fascinating aspect of the systemic immune response [2]. Studies have shown that mosquitoes can retain a form of immunological memory against previously encountered arboviruses. This memory response allows them to respond more rapidly and efficiently to subsequent infections with the same virus, significantly reducing the likelihood of virus transmission.

Understanding the molecular and cellular mechanisms behind how arboviruses are detected and controlled through the mosquito's systemic immune response is essential for devising effective vector control strategies. By targeting specific components of the mosquito's immune response, researchers and public health officials can develop novel interventions to limit arboviral transmission. One approach is the development of genetically modified mosquitoes with enhanced immune responses. These transgenic mosquitoes could be designed to express antiviral effectors, such as AMPs or siRNAs, which would enhance their ability to control arboviral infections. Another strategy involves using RNAi-based gene silencing to selectively inhibit viral replication in mosquitoes, thus reducing their capacity to transmit viruses to humans. Furthermore, insights into immune priming and memory responses in mosquitoes could lead to the development of vaccines that induce protective immune responses in mosquitoes against arboviruses. Such vaccines, if integrated into mosquito control programs, could significantly reduce the transmission of arboviral diseases in endemic regions [3].

Discussion

The detection of arboviruses through the mosquito's systemic immune response is a complex and critical process that plays a central role in determining the transmission dynamics of these viruses. Understanding the intricate interplay between arboviruses and the mosquito's immune system offers valuable insights into the development of innovative strategies for controlling arboviral diseases and reducing their impact on global public health. In this discussion, we will delve deeper into the significance of the mosquito's systemic immune response in arbovirus detection and its implications for vector control and public health. The innate immune response in mosquitoes acts as the first line of defense against arboviruses. It involves the rapid recognition and elimination of invading pathogens through the activation of various signalling pathways and the production of Antimicrobial Peptides (AMPs). Studies have shown that AMPs play a critical role in controlling arboviral infections by disrupting the viral envelope, inhibiting viral entry, and targeting viral replication. The effectiveness of the innate immune response in limiting arboviral replication within the mosquito is crucial in preventing the establishment of infection and subsequent transmission to humans [4].

The RNAi pathway is another essential component of the mosquito's immune response against arboviruses. Upon arboviral infection, the production of viral double-stranded RNA (dsRNA) triggers the generation of small interfering RNAs (siRNAs) through the RNAi pathway. These siRNAs guide the Argonaute protein to specifically target and degrade viral RNA, effectively limiting viral replication and spread. The RNAi pathway has been demonstrated to be highly effective against various arboviruses, including Dengue virus, Chikungunya virus, and Zika virus. Harnessing this antiviral defense mechanism holds promising potential for developing RNAi-based strategies to control mosquito populations and reduce arbovirus transmission. The mosquito's midgut acts as a crucial barrier against arboviral infection. It produces Reactive Oxygen Species (ROS) and activates autophagy pathways to limit viral replication within the gut. Additionally, the midgut epithelial cells sense invading pathogens and initiate an antiviral immune response, leading to the expression of antiviral effectors like AMPs and siRNAs. Not all ingested viruses can overcome these midgut barriers, and those that do must successfully disseminate to other tissues, particularly the salivary glands, to establish an infection and transmit the virus. The systemic immune response, including the action of haemocytes and antiviral molecules produced by the fat body, plays a vital role in controlling arbovirus dissemination.

The phenomenon of immune priming and memory response in mosquitoes is intriguing and offers valuable opportunities for arbovirus control. When a mosquito is exposed to a sub lethal dose of an arbovirus, it can mount an enhanced immune response upon subsequent viral exposure, providing protection against future infections with the same or related arboviruses. Understanding the mechanisms behind immune priming and memory can pave the way for the development of vaccines that induce protective immune responses in mosquitoes [5]. Such vaccines could significantly reduce the transmission of arboviral diseases in endemic regions and offer a novel approach to vector control.

The significance of the mosquito's systemic immune response in arbovirus detection has profound implications for vector control and public health. By targeting specific components of the mosquito's immune system, researchers and public health officials can develop innovative interventions to limit arboviral transmission. For instance, the use of genetically modified mosquitoes with enhanced immune responses or RNAi-mediated gene silencing has the potential to reduce the mosquito's capacity to transmit arboviruses to humans. Additionally, understanding immune priming and memory in mosquitoes can lead to the development of vaccines that induce protective immune responses in these vectors, further reducing arbovirus transmission.

While progress has been made in understanding the mosquito's systemic immune response against arboviruses, several challenges remain. The complex and dynamic nature of the mosquito-virus interactions necessitates a comprehensive approach that considers the diversity of arboviral strains and mosquito species. Additionally, ethical and regulatory considerations surround the use of genetically modified mosquitoes, requiring careful assessment before widespread implementation. In the future, further research is needed to elucidate the mechanisms underlying immune priming and memory responses in mosquitoes fully. This knowledge could be instrumental in designing effective vaccines and other innovative strategies to disrupt the transmission cycle of arboviruses [6].

Conclusion

Arboviruses continue to pose a significant threat to global public health, with the transmission dynamics heavily reliant on the mosquito vectors' competence. The mosquito's systemic immune response represents a multifaceted defense mechanism against invading arboviruses, encompassing innate immunity, RNAi-mediated gene silencing, midgut barriers, and immune priming/memory responses. Understanding how arboviruses are detected through the mosquito's systemic immune response provides critical insights into developing novel strategies for vector control and arbovirus prevention. Targeting the mosquito's immune response can ultimately lead to the development of more effective and sustainable approaches to combat arboviral diseases and reduce their burden on human populations worldwide.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Lee, Hobart, Sara Halverson and Ngozi Ezinwa. "Mosquito-borne diseases." Prim Care-Clin Off Pract 45 (2018): 393-407.

Google Scholar, Crossref, Indexed at

2. Weaver, Scott C., Caroline Charlier, Nikos Vasilakis and Marc Lecuit, et al. "Zika, chikungunya, and other emerging vector-borne viral diseases." Annu Rev Med 69 (2018): 395-408.

Google Scholar, Crossref, Indexed at

3. Huang, Yan-Jang S., Stephen Higgs and Dana L. Vanlandingham. "Emergence and re-emergence of mosquito-borne arboviruses." Curr Opin Virol 34 (2019): 104-109.

Google Scholar, Crossref, Indexed at

4. Robert, Michael A., Anna M. Stewart-Ibarra and Elizabet L. Estallo. "Climate change and viral emergence: Evidence from Aedes-borne arboviruses." Curr Opin Virol 40 (2020): 41-47.

Google Scholar, Crossref, Indexed at

5. Blair, Carol D. and Ken E. Olson. "The role of RNA interference (RNAi) in arbovirus-vector interactions." Viruses 7 (2015): 820-843.

Google Scholar, Crossref, Indexed at

6. Blair, Carol D. "Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission." Future Microbiol 6 (2011): 265-277.

Google Scholar, Crossref, Indexed at